Shanghai Haohai Biological Technology Co Ltd
SSE:688366

Watchlist Manager
Shanghai Haohai Biological Technology Co Ltd Logo
Shanghai Haohai Biological Technology Co Ltd
SSE:688366
Watchlist
Price: 61.2 CNY -1.66% Market Closed
Market Cap: 14.3B CNY
Have any thoughts about
Shanghai Haohai Biological Technology Co Ltd?
Write Note

Shanghai Haohai Biological Technology Co Ltd
Inventory

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shanghai Haohai Biological Technology Co Ltd
Inventory Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Inventory CAGR 3Y CAGR 5Y CAGR 10Y
Shanghai Haohai Biological Technology Co Ltd
SSE:688366
Inventory
ÂĄ526.2m
CAGR 3-Years
27%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Inventory
ÂĄ3B
CAGR 3-Years
72%
CAGR 5-Years
92%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Inventory
ÂĄ690.4m
CAGR 3-Years
-14%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Inventory
ÂĄ905.5m
CAGR 3-Years
31%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Inventory
ÂĄ15.7B
CAGR 3-Years
33%
CAGR 5-Years
43%
CAGR 10-Years
57%
Imeik Technology Development Co Ltd
SZSE:300896
Inventory
ÂĄ49.8m
CAGR 3-Years
23%
CAGR 5-Years
31%
CAGR 10-Years
N/A
No Stocks Found

Shanghai Haohai Biological Technology Co Ltd
Glance View

Market Cap
14.3B CNY
Industry
Biotechnology

Shanghai Haohai Biological Technology Co., Ltd. operates at the cutting edge of the biopharmaceutical industry, specializing in regenerative medicine, medical aesthetics, and other biotechnology applications. Founded on the principles of innovation and science-driven solutions, the company has built an impressive portfolio that underscores its expertise in biological materials. Core to its operations is the development and commercialization of hyaluronic acid products, pivotal in fields such as ophthalmology, wound care, and more recently, dermal fillers for aesthetic treatments. Haohai Biological leverages high-end biotechnological processes to produce its offerings, ensuring that they meet the highest standards of quality and efficacy—a strategy that has allowed it to capture significant market share both domestically within China and beyond its borders. The revenue streams of Haohai Biological are as diversified as its product lines. The company generates income primarily through the sale of its high-margin pharmaceutical and medical device products. It has strategically positioned itself in the burgeoning market for medical aesthetics, where demand for cosmetic enhancements is rapidly growing, fueled by a global shift toward non-invasive procedures. Additionally, its ophthalmic products, crucial for surgeries and various ocular conditions, continue to be significant revenue drivers. Beyond product sales, Haohai invests in licensing its technologies and forging strategic partnerships with international firms, further enhancing its market reach and capitalizing on global biotechnology trends. This multifaceted approach positions the company not only as a producer but as a leader in scientific innovation and commercialization in the biotechnology sector.

Intrinsic Value
81.96 CNY
Undervaluation 25%
Intrinsic Value
Price

See Also

What is Shanghai Haohai Biological Technology Co Ltd's Inventory?
Inventory
526.2m CNY

Based on the financial report for Dec 31, 2023, Shanghai Haohai Biological Technology Co Ltd's Inventory amounts to 526.2m CNY.

What is Shanghai Haohai Biological Technology Co Ltd's Inventory growth rate?
Inventory CAGR 5Y
22%

Over the last year, the Inventory growth was 8%. The average annual Inventory growth rates for Shanghai Haohai Biological Technology Co Ltd have been 27% over the past three years , 22% over the past five years .

Back to Top